Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
批准号:
7540125
负责人:
UGUR OZERDEM
金额:
$8.95万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2009-07-31
关键词:
AdultBiological AssayBlood CirculationBone MarrowBone Marrow TransplantationCSPG4 geneCell ProliferationCellsCoculture TechniquesCorneaCorneal NeovascularizationCutaneous MelanomaEndothelial CellsEndotheliumFibroblast Growth Factor 2GenotypeGoalsHypersensitivityHypertensionIn VitroIntercellular FluidInvestigationInvestmentsLeadLinkLiquid substanceMalignant NeoplasmsMalignant Peripheral Nerve Sheath TumorMediatingModelingMusNG2 antigenNeurofibromatosesNeurofibromatosis 1NumbersPathologic NeovascularizationPatientsPericytesPropertyProteoglycanRelative (related person)Research PersonnelRoleSimulateStimulusTestingTherapeuticTissuesTransplantationWild Type Mousechemotherapeutic agentenhanced green fluorescent proteinimprovedinterstitialmortalitymouse modelneovascularneovascularizationpressureprogenitorprogramsreceptorreconstitutionresearch studyresponsetumortumor progressionvasculogenesis
中文摘要
描述(由申请人提供):这是R21申请的重新提交。恶性周围神经鞘肿瘤(MPNST)是最常见的恶性肿瘤,也是导致1型神经纤维瘤病(NF1)死亡的主要原因。MPNST的两个关键问题是新生血管和高间质液压力(IFP)。NG2蛋白多糖、Nf1单倍不足(Nf1+/-)和新血管细胞对新血管刺激的加速反应是这两个问题的基础。该建议的基本假设是,MPNST的新生血管和间质液高血压可以通过抑制NG2蛋白多糖和Nf1单倍功能不全来抵消。我们建议在MPNST中建立血管生成和血管生成周细胞作为降低间质液压力和新生血管的靶点。具体目标表征Nf1小鼠模型中Nf1+/-骨髓源性周细胞和内皮细胞对病理性血管生成的加速贡献。我们将测试从野生型小鼠(Nf1+/+)到Nf1+/-小鼠的骨髓移植是否会减少MPNST的血管生成并提高生存率。具体目标2。表征NG2在调节nf1驱动的新生血管和间质性高血压中的作用。我们将确定周细胞ng2在MPNST中促进新生血管和间质性高血压的程度。我们将测试NG2和Nf1单倍不全联合抑制是否会由于NG2和Nf1单倍不全之间的协同作用而最大限度地抑制新生血管。具体目标3。揭示NG2在Nf1单倍不足新生血管细胞对bFGF加速反应中的作用。先前的研究发现bFGF过敏是Nf1单倍体功能不全中细胞过度增殖的原因。我们拟确定Nf1单倍体不足和NG2之间是否存在由bfgf驱动的协同机制。具体目标确定NF1小鼠模型中MPNST高间质液压力的来源。我们将测试抑制NG2是否通过减少异常周细胞数量及其异常收缩特性来降低肿瘤内压缩收缩力,从而导致间质液压力降低。
英文摘要
DESCRIPTION (provided by applicant): This is a resubmission of an R21 application. Malignant peripheral nerve sheath tumors (MPNST) are the most common malignant tumor, and the leading cause of mortality in neurofibromatosis type 1 (NF1). Two critical issues in MPNST are neovascularization and high interstitial fluid pressure (IFP). The NG2 proteoglycan, Nf1 haploinsufficiency (Nf1+/-), and accelerated response of neovascular cells to neovascular stimuli are fundamental to both issues. The underlying hypothesis for this proposal is that neovascularization and interstitial fluid hypertension in MPNST can be counteracted by inhibiting both NG2 proteoglycan and Nf1 haploinsufficiency. We propose to establish both vasculogenic and angiogenic pericytes as targets to reduce interstitial fluid pressure and neovascularization in MPNST. Specific Aim 1. Characterize the accelerated contribution of Nf1+/- bone marrow-derived pericytes and endothelial cells to pathological vasculogenesis in NF1 mouse model. We will test whether bone marrow transplantation from wild type mice (Nf1+/+) to Nf1+/- mice reduces vasculogenesis and improves survival in MPNST. Specific Aim 2. Characterize the roles for NG2 in modulation of NF1-driven neovascularization, and in interstitial hypertension. We will determine the extent to which pericyte-NG2 contributes to neovascularization and interstitial hypertension in MPNST. We will test whether the combined inhibition of NG2 and Nf1 haploinsufficiency will maximally inhibit neovascularization due to synergy between NG2, and Nf1 haploinsufficiency. Specific Aim 3. Reveal the role for NG2 in accelerated response of Nf1 haploinsufficient neovascular cells to bFGF. Previous investigations identified bFGF hypersensitivity as a cause of excessive cell proliferation in Nf1 haploinsufficiency. We propose to determine whether there is a bFGF-driven synergistic mechanism linking Nf1 haploinsufficiency and NG2. Specific Aim 4. Identify the origin of high interstitial fluid pressure in MPNST in the NF1 mouse model. We will test whether inhibition of NG2 results in a decrease in interstitial fluid pressure due to decreasing compressive contractile forces within the tumor by decreasing the abnormal number of pericytes and their abnormal contraction properties.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1159/000226258
发表时间:
2009
期刊:
Ophthalmic research
影响因子:
2.1
作者:
[Ozerdem U]
通讯作者:
Ozerdem U
Improving transcapillary transport by reducing interstitial fluid pressure
-
批准号:7387153
-
项目类别:
-
资助金额:$9.47万
-
财政年份:2008
-
负责人:UGUR OZERDEM
-
依托单位:
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
-
批准号:7143733
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2006
-
负责人:UGUR OZERDEM
-
依托单位:
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
-
批准号:7267968
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2006
-
负责人:UGUR OZERDEM
-
依托单位:
PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1
-
批准号:6757878
-
项目类别:
-
资助金额:$9.78万
-
财政年份:2003
-
负责人:UGUR OZERDEM
-
依托单位:
PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1
-
批准号:6797630
-
项目类别:
-
资助金额:$9.78万
-
财政年份:2003
-
负责人:UGUR OZERDEM
-
依托单位:
海外基金